Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ULLEVÅL HAGEBY APOTEK AS
AS
Active
Org 993994189
Niels Henrik Abels vei 2, 0851 Oslo
Retail sale of pharmaceutical products · NACE 4773
Est. 2009
5 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 11,2M
+15% vs 2023
EBITDA margin
5.8%
+26% vs 2023
Equity ratio
37.3%
Financial strength
Net profit 2024
NOK 490K
+29% vs 2023
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
1M
2020
0M
-100%
2021
0M
0%
2022
1M
+100%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 11,2M
+15%
EBITDA
NOK 651K
+26%
Net profit
NOK 490K
+29%
Total assets
NOK 2,9M
+15%
Equity
NOK 1,1M
+21%
Employees
5
—
Company information
Legal name
ULLEVÅL HAGEBY APOTEK AS
Org number
993994189
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
29. april 2009
Share capital
NOK 100 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Salg av apotekvarer.
Contact
Address
Niels Henrik Abels vei 2, 0851 Oslo
Phone
+4723202000
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
3M
6M
9M
13M
9M
2020
9M
2021
9M
2022
10M
2023
11M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2020
0M
2021
0M
2022
1M
2023
1M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
9 116
8 735
8 523
9 689
11 189
Staff expenses
−1 089
−1 588
−1 295
−1 212
−1 248
EBITDA
805
319
353
517
651
Depreciation & amort.
−17
−29
−16
−13
−10
EBIT
788
290
338
505
641
Net financials
−4
−2
−0
−0
−1
Profit before tax
784
288
338
504
640
Tax
174
63
75
125
150
Net profit
610
224
263
380
490
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
2 144
2 141
2 211
2 517
2 888
Equity
671
895
1 158
887
1 077
Long-term debt
0
0
2
0
202
Short-term debt
1 473
1 246
1 051
1 629
1 609
Total debt
1 473
1 246
1 053
1 629
1 811
Financial ratios
5-year trend
EBITDA margin
5.8%
This company
15.8%
Market median
-63% vs market
2020
2024
Equity ratio
37.3%
This company
38.2%
Market median
+2% vs market
2020
2024
Return on equity
45.5%
This company
18.4%
Market median
+147% vs market
2020
2024
Net profit margin
4.4%
This company
8.1%
Market median
-46% vs market
2020
2024
Asset turnover
3.87×
This company
1.12×
Market median
+246% vs market
2020
2024
Debt / equity
1.68×
This company
0.62×
Market median
-171% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
BA
Basel Adi
Chief Executive Officer
Chief Executive Officer
2009
KR
Kathrina Ramberg
Deputy Member
Deputy Member
2009
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
MA
Maher Adi
Chairman
2009
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Adi Holding As
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Adi Holding As
ULLEVÅL HAGEBY APOTEK AS
(this company)
Board network connections
Board members of ULLEVÅL HAGEBY APOTEK AS also hold positions in
0
other companies.
Person
Role here
Other companies
Basel Adi
Chief Executive Officer
0 companies
Kathrina Ramberg
Deputy Member
0 companies
Maher Adi
Chairman
0 companies